Kratom patch could ease stubborn neck pain without pills

NCT ID NCT07713771

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a skin patch containing mitragynine, the main active compound from the kratom plant, can reduce pain in people with chronic myofascial pain syndrome in the upper neck and shoulder muscles. Participants aged 18 to 50 with pain lasting over three months will receive either the active patch or a placebo patch. The goal is to see if the patch provides better pain relief than a dummy patch, offering a potential alternative to oral medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a topical patch containing 10 mg of mitragynine, the main active compound from the kratom plant
What this could lead to
If effective, this patch could offer a new, non-oral option for managing chronic muscle pain without the side effects of oral painkillers.
What could go wrong
This is a small, early-phase trial, so results may not apply to everyone. The patch may not work better than a placebo, and skin irritation is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOFASCIAL PAIN SYNDROME - NECK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Prince of Songkla university

    Songkhla, Changwat Songkhla, 90110, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.